In conclusion, the results of the present study show that a BAFF blockade might modulate CD4+ T-cell-induced acute GVHD early after allo-BMT and the possibility of simultaneously controlling chronic GVHD, which may appear later after allo-BMT. This evidence concerns the gene TNFSF13B and chronic graft versus host disease.